Thorium-232
WikiDoc Resources for Thorium-232 |
Articles |
---|
Most recent articles on Thorium-232 Most cited articles on Thorium-232 |
Media |
Powerpoint slides on Thorium-232 |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Thorium-232 at Clinical Trials.gov Clinical Trials on Thorium-232 at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Thorium-232
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Thorium-232 Discussion groups on Thorium-232 Patient Handouts on Thorium-232 Directions to Hospitals Treating Thorium-232 Risk calculators and risk factors for Thorium-232
|
Healthcare Provider Resources |
Causes & Risk Factors for Thorium-232 |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Thorium-232 is the primary abundant nuclide of thorium. It is a slightly unstable radionuclide that is found in the earth's crust. It is a fertile material able to absorb a neutron and undergo transmutation into a nuclide that is able to support fission (uranium-233).
In the form of Thorotrast, a thorium oxide suspension, it was used as contrast medium in early X-ray diagnostics. Thorium-232 is now classified as carcinogenic. The half-life of thorium-232 is 1.405Template:E years. Template:WH Template:WikiDoc Sources